April 07, 2017 – Yesterday’s date marks a giant leap into the new area of direct-to-consumer theragenomics (DTCT) in that the American Food & Drug Administration (FDA) has allowed the marketing of the first direct-to-consumer Genetic Health Risk (GHR) tests that …

A giant leap in direct-to-consumer theragenomics (DTCT) Read more »